Up to 76% Remission in 90 Days
Published research using Psynary data shows structured monitoring supports clinician-led care associated with higher remission rates.
Why Remission Matters
True recovery requires complete remission, not just partial improvement.
Complete Recovery Goal
Remission, not partial response, is the true goal in depression treatment.
Prevents Relapse
Research shows residual symptoms are associated with higher relapse and long-term disability risk.
Earlier Achievement
Published studies show structured monitoring supports clinician-led care associated with earlier remission.
Clinical Evidence
Published findings across multiple clinical studies where clinicians used structured Psynary data.
📊 Key Findings
Clinical Studies Comparison
Tokyo Clinic Re-audit (2018)
76%Within 90 days - Highest recorded remission rate
Tokyo Clinic Audit (2017)
71%97% in patients completing full structured monitoring
OptiMA1 (Japan + NZ)
44%Larger multi-national dataset
STAR*D Trial (Standard Care)
37%Largest depression trial baseline
Clinical Impact
Research associates structured early monitoring with benefits to patients and healthcare systems.
Earlier Data for Clinicians
Structured monitoring surfaces data earlier, supporting clinician review and informed care decisions.
Supporting Cost Efficiency
Earlier clinician access to structured data may support reduced indirect costs through timely care adjustments.
Clinical Trial Quality
Research data collected via Psynary has been compared favourably against STAR*D benchmarks.
Time to Remission Comparison
See the Research Behind the Data
Join clinicians who use Psynary to collect structured patient-reported data and support informed clinical decisions.